GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a prominent focus in healthcare research, largely due to its remarkable impact on treating ailments such as type 2 diabetes and obesity. Ongoing studies have revealed that beyond glucose management, GLP-1 medications offer promise for heart health and possibly neurodegen